ZVSAのROE（自己資本利益率）は？

Zyversa Therapeutics Inc.のROEは173.38%です。

ZVSAの配当利回りは？

Zyversa Therapeutics Inc.の配当利回りは0.00%です。

ZVSAの品質スコア（Quality Score）は？

当社のAIはZVSAの総合財務品質を100点中62点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

ZVSAは今が買い時ですか？

当社AIのタイミングスコアは100点中0点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

ZVSAはどのセクターに属しますか？

Zyversa Therapeutics Inc.はHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

ZVSA (NASDAQ) 株価分析 | Zyversa Therapeutics Inc.

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2026-03-31)

ZVSA AI Analysis Summary

Our AI summary for ZVSA: Zyversa Therapeutics Inc. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of 173.38%, a dividend yield of 0.00%. Its financial Quality Score stands at 62/100 — mid-range fundamentals relative to the market. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ZVSA

Zyversa Therapeutics Inc.

US:NASDAQ STOCK Healthcare >> Biotechnology News 57

USD 0.10

0.00 (3.40%) Day Change

Watchlist Portfolio Compare Chart

-84.96

D/E

173.4%

ROE

-3.3%

ROA

0.00%

Div Yield

ZYVERSA THERAPEUTICS INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.10 Price 0.00 (3.40%) Day Change	NEWS SCORE: 57

ZVSA, ファンダメンタルスコアはok ( ファンダメンタル = 62) そしてテクニカルスコアは ...(Sign In to See)...

No price data to display chart for the last 3-months of this stock

62 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: ROAが低い
平均ROEが低い
ROAがROEに比べて低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Deepscope 分析

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	57
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.10
PBV / Sector	N/A / 44,105.10
Earning Per Share	-2.52

PE / Sector	N/A / 19.37
PEG or PE/Growth / Sector	N/A / 1.06
Average 1M Daily Value	1924.319120000000
Average 1W Daily Value	765.284500000000

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 97.23
NPM Average (%) / Sector	N/A / -1,697.84
NPM Change Average (%) / Sector	N/A / 5,097.59
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-3.30 / 185,260.64
ROA Average (%) / Sector	-9,232.88 / 36,684.64
ROA Change Average (%) / Sector	3,419.13 / 422,221.42 GREAT
ROE (%) / Sector	173.38 / 243,761.81 GREAT
ROE Average (%) / Sector	-22,252.10 / 48,758.38
ROE Change Average (%) / Sector	26,110.09 / 424,967.86 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.42

登録情報

Analyze Date	2026-08-06 08:00:58
Symbol	ZVSA
Name	ZYVERSA THERAPEUTICS INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	8.10 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1.00 / 9,702.21

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2200 N. Commerce Parkway, Weston, FL, United States, 33326

Phone: 754 231 1688

Website: https://www.zyversa.com

Sector: Healthcare >> Biotechnology

Description: ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial for the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100 a humanized monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of numerous inflammatory diseases, with cardiometabolic conditions associated with obesity as the lead. The company has a license agreement with L&F Research LLC, and InflamaCORE, LLC. ZyVersa Therapeutics, Inc. was founded in 2014 and is based in Weston, Florida.